Back to search

Article

Understanding barriers to the introduction of precision medicines in non-small cell lung cancer: A qualitative interview protocol

2018-03-08

Abstract excerpt

<h4>Background: </h4> While precision medicines targeting genetic mutations and alterations in non-small cell lung cancer (NSCLC) have been available since 2010, their adoption into clinical practice has been slow. Evidence suggests that a number of barriers, such as insufficient clinician knowledge, a need for training of test providers, or a lack of specific clinical guidelines, may slow the implementation of pr...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
b1066818-0eda-5549-8cc3-cb7edeba2563
DOI
10.12688/wellcomeopenres.13976.1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Understanding barriers to the introduction of precision medicines in non-small cell lung cancer: A qualitative interview protocolDOI 10.12688/wellcomeopenres.13976.1
Understanding barriers to the introduction of precision medicine in non-small cell lung cancer: a qualitative interview studySemantic proximity
Difficulties on the access to innovative targeted therapies for lung cancer in Spain.Semantic proximity
Investigating Needs to Develop Training in Precision Medicine for Frontline Healthcare Professionals: A Focus Group StudySemantic proximity
Understanding the medication experience of patients with advanced non-small cell lung cancer taking epidermal growth factor receptor-tyrosine kinase inhibitors: A phenomenological study.Semantic proximity
Awareness, Knowledge, Perceived Benefits, and Barriers Regarding Precision Medicine and Willingness to Participate in a National Registry: Comparison of Cancer Patients and the General PopulationSemantic proximity
Does The Reformed Cancer Drug Fund Generate Evidence On Effectiveness? A Cross-sectional Analysis On Publicly Accessible DocumentationSemantic proximity
Evaluation of the clinical guidelines for the diagnosis and treatment of non-small cell lung cancer (NSCLC) in Iran via the guideline appraisal with AGREE IISemantic proximity
Primary healthcare professionals’ perspectives on patient help-seeking for lung cancer warning signs and symptoms: a qualitative studySemantic proximity
Barriers and facilitators to the implementation of guidelines in rare diseases: A systematic reviewSemantic proximity
Protocol for a Feasibility study incorporating a Randomised Pilot Trial with an Embedded Process Evaluation and Feasibility Economic Analysis of ThinkCancer!: A primary care intervention to expedite cancer diagnosis in WalesSemantic proximity
The Cancer Treatment Helpline – a retrospective study of the NHS Tayside ExperienceSemantic proximity
Challenges That Hinder the Translation of Clinical Advances Into Practice: Results From an International Assessment in Colorectal Cancer.Semantic proximity
Select a neighboring publication to make it the new centre.